Markus Follmann

936 total citations
12 papers, 376 citations indexed

About

Markus Follmann is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Markus Follmann has authored 12 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Organic Chemistry. Recurrent topics in Markus Follmann's work include Nitric Oxide and Endothelin Effects (5 papers), Phosphodiesterase function and regulation (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Markus Follmann is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Phosphodiesterase function and regulation (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Markus Follmann collaborates with scholars based in Germany. Markus Follmann's co-authors include Johannes‐Peter Stasch, Michael G. Hahn, Alexander Straub, Hartmut Schirok, Nils Griebenow, Joachim Mittendorf, Friederike Stoll, Ingo V. Hartung, Martina Schäfer and Peter Sandner and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Markus Follmann

12 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Follmann Germany	9	148	122	99	74	48	12	376
Satoru Tamaoki Japan	11	131 0.9×	132 1.1×	78 0.8×	67 0.9×	34 0.7×	17	374
Paula Savage United States	12	187 1.3×	228 1.9×	168 1.7×	170 2.3×	42 0.9×	40	528
Jens‐Kerim Ergüden Germany	6	147 1.0×	39 0.3×	65 0.7×	107 1.4×	73 1.5×	8	423
Yuting Zheng United States	12	424 2.9×	65 0.5×	146 1.5×	36 0.5×	17 0.4×	20	654
A. C. S. A. Herrera Brazil	12	207 1.4×	49 0.4×	55 0.6×	33 0.4×	41 0.9×	14	525
Maria A. Palomo United States	13	264 1.8×	213 1.7×	231 2.3×	112 1.5×	39 0.8×	19	522
Tadeu L. Montagnoli Brazil	12	127 0.9×	39 0.3×	110 1.1×	71 1.0×	118 2.5×	21	396
Tomoyoshi Koyanagi Japan	12	352 2.4×	48 0.4×	104 1.1×	18 0.2×	12 0.3×	20	481
Isak Im South Korea	12	295 2.0×	99 0.8×	26 0.3×	147 2.0×	9 0.2×	16	534
Larissa Wilsie United States	10	162 1.1×	83 0.7×	37 0.4×	71 1.0×	7 0.1×	10	428

Countries citing papers authored by Markus Follmann

Since Specialization

Citations

This map shows the geographic impact of Markus Follmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Follmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Follmann more than expected).

Fields of papers citing papers by Markus Follmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Follmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Follmann. The network helps show where Markus Follmann may publish in the future.

Co-authorship network of co-authors of Markus Follmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Follmann. A scholar is included among the top collaborators of Markus Follmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Follmann. Markus Follmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Roehrig, Susanne, Eloísa Jiménez Núñez, Katharina Meier, et al.. (2023). Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Journal of Medicinal Chemistry. 66(17). 12203–12224. 14 indexed citations

Wunder, Frank, Johannes‐Peter Stasch, Thomas Mondritzki, et al.. (2023). Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY‐747 designed for the treatment of resistant hypertension. British Journal of Pharmacology. 180(19). 2500–2513. 3 indexed citations

Meibom, Daniel, André P. Dieskau, Frank Eitner, et al.. (2022). BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of Medicinal Chemistry. 65(24). 16420–16431. 7 indexed citations

Sandner, Peter, Markus Follmann, Michael G. Hahn, et al.. (2021). Soluble GC stimulators and activators: Past, present and future. British Journal of Pharmacology. 181(21). 4130–4151. 67 indexed citations

Sandner, Peter, Alexandros Vakalopoulos, Michael G. Hahn, Johannes‐Peter Stasch, & Markus Follmann. (2021). Soluble guanylate cyclase stimulators and their potential use: a patent review. Expert Opinion on Therapeutic Patents. 31(3). 203–222. 22 indexed citations

Follmann, Markus, Hans Briem, Andreas Steinmeyer, et al.. (2018). An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer — against all odds?. Drug Discovery Today. 24(3). 668–672. 33 indexed citations

Rackelmann, Nils, Hans Matter, Heinrich Englert, et al.. (2016). Discovery and Optimization of 1-Phenoxy-2-aminoindanes as Potent, Selective, and Orally Bioavailable Inhibitors of the Na⁺/H⁺ Exchanger Type 3 (NHE3). Journal of Medicinal Chemistry. 59(19). 8812–8829. 12 indexed citations

Halland, Nis, Jörg Czech, Werngard Czechtizky, et al.. (2016). Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa). Journal of Medicinal Chemistry. 59(20). 9567–9573. 9 indexed citations

Halland, Nis, Mark Brönstrup, Jörg Czech, et al.. (2015). Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin. Journal of Medicinal Chemistry. 58(11). 4839–4844. 37 indexed citations

10.

Griebenow, Nils, Hartmut Schirok, Joachim Mittendorf, et al.. (2013). Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators. Bioorganic & Medicinal Chemistry Letters. 23(5). 1197–1200. 10 indexed citations

11.

Follmann, Markus, Nils Griebenow, Michael G. Hahn, et al.. (2013). The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators. Angewandte Chemie International Edition. 52(36). 9442–9462. 159 indexed citations

12.

Follmann, Markus, Nils Griebenow, Michael G. Hahn, et al.. (2013). Chemie und Biologie der Stimulatoren und Aktivatoren der löslichen Guanylatcyclase. Angewandte Chemie. 125(36). 9618–9639. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact